	US 11,986,513 B2
	GAL(1-15) and analogues thereof for use in the prevention and/or treatment of alcohol-related effects and disorders
Carmelo Millón Peñuela, Málaga (ES); Antonio Flores Burgess, Málaga (ES); Belén Gago Calderón, Málaga (ES); María Inmaculada García Fernandez, Málaga (ES); José Ángel Narváez Bueno, Málaga (ES); Luis Javier Santín Núñez, Málaga (ES); and Mª Zaida Díaz Cabiale, Málaga (ES)
Assigned to UNIVERSIDAD DE MÁLAGA, Málaga (ES)
Appl. No. 16/757,706
Filed by UNIVERSIDAD DE MÁLAGA, Málaga (ES)
PCT Filed Oct. 2, 2018, PCT No. PCT/ES2018/070634 § 371(c)(1), (2) Date Apr. 20, 2020, PCT Pub. No. WO2019/068948, PCT Pub. Date Apr. 11, 2019.
Claims priority of application No. ES201731170 (ES), filed on Oct. 2, 2017.
Prior Publication US 2023/0158115 A1, May 25, 2023
Int. Cl. A61K 38/22 (2006.01); A61K 38/10 (2006.01); A61P 39/02 (2006.01)

CPC A61K 38/22 (2013.01) [A61P 39/02 (2018.01)]

5 Claims

1. A method for prevention or treatment, or both, of alcohol-related effects and disorders in a subject in need thereof, comprising administering to the subject galanin(1-15) compound consisting of Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala (GWTLNSAGYLLGPHA) (SEQ ID NO: 1), or a pharmaceutically acceptable salt thereof.